Table 1 Subject characteristics

Demographics

n = 12

Age, years-median (IQR)

30 (25.5, 40)

Gender (female)-n (%)

11 (91.7%)

Race

 White

8 (66.7%)

 Asian

5 (41.7%)

Medical history

 BMI, kg/m²-median (IQR)

21.7 (20.5, 24.2)

Medication history

 None

3 (25%)

 Hypertension

1 (8.3%)

 Hypothyroidism

1 (8.3%)

 GERD

1 (8.3%)

 Asthma

6 (50%)

Baseline lab values

 Hemoglobin, g/dL-median (IQR)

13.1 (12.8, 14.6)

 Hematocrit, %-median (IQR)

40.4 (38.8, 44.0)

 WBC count, 10³/μL-median (IQR)

6.2 (5.5, 7.3)

 Platelet count, 10³/μL-median (IQR)

292 (253.5, 346)

Treatment completion (full completion = 21 doses/intervention)

 Placebo treatment completion

  Full completion-n (%)

10 (83.3%)

  Average doses per person-mean (SD)

20.8 (0.6)

 Capsule treatment completion

  Full completion-n (%)

10 (83.3%)

  Average doses per person-mean (SD)

20.8 (0.6)

 Tea treatment completion

  Full completion-n (%)

10 (83.3%)

  Average doses per person-mean (SD)

20.8 (0.4)